Free Trial

Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume

$987.27
+4.98 (+0.51%)
(As of 04:27 PM ET)

Regeneron Pharmaceuticals Short Interest Data

Current Short Interest
1,570,000 shares
Previous Short Interest
1,390,000 shares
Change Vs. Previous Month
+12.95%
Dollar Volume Sold Short
$1.40 billion
Short Interest Ratio
3.4 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
110,190,000 shares
Percentage of Shares Shorted
1.42%
Today's Trading Volume
310,879 shares
Average Trading Volume
485,114 shares
Today's Volume Vs. Average
64%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Regeneron Pharmaceuticals ?

Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

REGN Short Interest Over Time

REGN Days to Cover Over Time

REGN Percentage of Float Shorted Over Time

Regeneron Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20241,570,000 shares $1.40 billion +13.0%N/A3.4 $890.66
4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56
3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49
3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47
2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09
2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73
1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78
1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20
12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29
12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14
11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81
11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38
10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89
10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63
9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96
9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40
8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49
8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91
7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91
7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52
6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54
6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07
5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56
5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96
4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79
4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33
3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67
3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30
2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42
2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40
1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47
1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13
12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49
12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27
11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70
11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73
10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75
10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06
9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87
9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now
8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06
8/15/20222,930,000 shares $1.88 billion -4.6%2.9%4.6 $643.29
7/31/20223,070,000 shares $1.79 billion +7.3%3.0%4.6 $581.69
7/15/20222,860,000 shares $1.74 billion +3.3%2.8%4.3 $607.54
6/30/20222,770,000 shares $1.64 billion +7.4%N/A4.1 $591.13
6/15/20222,580,000 shares $1.45 billion +23.4%N/A3.7 $561.19
5/31/20222,090,000 shares $1.39 billion -4.1%N/A3.1 $664.74
5/15/20222,180,000 shares $1.41 billion +0.9%N/A3.4 $645.52
4/30/20222,160,000 shares $1.42 billion +0.5%N/A3.2 $659.11
4/15/20222,150,000 shares $1.58 billion -2.3%2.1%3 $733.02
3/31/20222,200,000 shares $1.54 billion -8.0%2.1%3 $698.42
3/15/20222,390,000 shares $1.59 billion +6.7%2.3%3.3 $665.93
2/28/20222,240,000 shares $1.39 billion +4.7%2.2%3 $618.36
2/15/20222,140,000 shares $1.35 billion +19.6%2.1%2.8 $630.15
1/31/20221,790,000 shares $1.09 billion -1.7%1.7%2.4 $608.59
1/15/20221,820,000 shares $1.12 billion +11.0%1.8%2.4 $615.24
12/31/20211,640,000 shares $1.04 billion +7.2%1.6%2.2 $631.52
12/15/20211,530,000 shares $1.01 billion +3.4%1.5%1.9 $657.93
11/30/20211,480,000 shares $942.06 million -8.1%1.4%2 $636.53
11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73
10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94
10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24
9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18
9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00
8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40
8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79
7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61
7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32
6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54
6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49
5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43
5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17
4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00
4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16
3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67
3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46
2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19
2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54
1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27
1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91
12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30
12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38
11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05
11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43
10/30/20202,170,000 shares $1.21 billion -6.9%2.1%2.4 $555.79
10/15/20202,330,000 shares $1.40 billion +13.7%2.3%2.7 $600.82
9/30/20202,050,000 shares $1.15 billion +28.1%2.0%2.4 $559.78
9/15/20201,600,000 shares $927.84 million +0.6%1.6%2.1 $579.90
8/31/20201,590,000 shares $985.69 million -0.6%1.6%2 $619.93
8/14/20201,600,000 shares $980.11 million -15.3%1.6%1.4 $612.57
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now
7/31/20201,890,000 shares $1.19 billion -5.0%1.9%1.5 $632.07
7/15/20201,990,000 shares $1.28 billion -6.1%1.9%1.5 $641.23
6/30/20202,120,000 shares $1.32 billion -14.2%2.0%1.5 $623.65
6/15/20202,470,000 shares $1.46 billion +24.1%2.3%1.7 $590.57
5/29/20201,990,000 shares $1.22 billion +11.8%1.9%1.3 $612.81
5/15/20201,780,000 shares $1.03 billion -4.8%2.1%1.2 $576.72
4/30/20201,870,000 shares $983.40 million -7.0%2.2%1.4 $525.88
4/15/20202,010,000 shares $1.03 billion +12.9%2.5%1.5 $511.69
3/31/20201,780,000 shares $1.01 billion -30.4%2.2%1.4 $566.21
3/13/20202,558,900 shares $1.31 billion -11.2%3.1%2 $512.96
2/28/20202,880,000 shares $1.31 billion +8.7%3.5%2.9 $455.63
2/14/20202,650,000 shares $1.26 billion -8.3%3.2%3 $475.02
1/31/20202,890,000 shares $1.32 billion +10.3%3.5%3.5 $457.92
1/15/20202,620,000 shares $1.04 billion +5.7%3.2%3.4 $396.75
12/31/20192,480,000 shares $856.29 million +0.8%3.0%3.4 $345.28
8/15/20192,351,800 shares $669.63 million -7.4%2.9%2.8 $284.73

REGN Short Interest - Frequently Asked Questions

What is Regeneron Pharmaceuticals' current short interest?

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,570,000 shares of REGN short. Learn More on Regeneron Pharmaceuticals' current short interest.

What is a good short interest ratio for Regeneron Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 3.0. Learn More on Regeneron Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Regeneron Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, PEAK6 Investments LLC, JPMorgan Chase & Co., Twin Tree Management LP, XR Securities LLC, SG Americas Securities LLC, Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Covenant Asset Management LLC, Nomura Holdings Inc., and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Regeneron Pharmaceuticals' short interest increasing or decreasing?

Regeneron Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,570,000 shares, an increase of 12.9% from the previous total of 1,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Regeneron Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies compare to Regeneron Pharmaceuticals: Vertex Pharmaceuticals Incorporated (1.50%), GSK plc (0.44%), Bristol-Myers Squibb (1.38%), Sanofi (0.22%), Zoetis Inc. (1.13%), Pfizer Inc. (1.10%), Takeda Pharmaceutical Company Limited (0.20%), Abbott Laboratories (0.84%), Royalty Pharma plc (3.59%), BeiGene, Ltd. (1.93%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Regeneron Pharmaceuticals stock?

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading up $14.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regeneron Pharmaceuticals?

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

How often is Regeneron Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:REGN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners